Weekly Intelligence · 11 articles
Vet Industry Intel: May 10 – May 16, 2026
High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.
Leadership Changes
NVA Taps Public Market Veteran for CFO, Signaling IPO Readiness
National Veterinary Associates (NVA) has appointed a public market veteran as its new Chief Financial Officer, signaling potential preparations for an initial public offering (IPO).
NVA
Regulatory & Policy
Zoetis (ZTS) Securities Fraud Investigation - Levi & Korsinsky
The U.S. Securities and Exchange Commission has opened an investigation into alleged securities fraud involving Zoetis, the veterinary pharmaceutical company.
Zoetis · Levi & Korsinsky · PR Newswire | NJ
Wrap up: FDA conditionally approves targeted therapy for canine CM/SM
The U.S. Food and Drug Administration conditionally approved a targeted therapy for canine CM/SM, marking a significant regulatory milestone in veterinary oncology.
FDA · DVM360
FDA conditionally approves drug for canine neuropathic pain
The FDA has granted conditional approval for a new drug aimed at treating canine neuropathic pain.
FDA · Veterinary Practice News
FDA issues no-objection letter for the first precision fermentation-derived animal protein for use in pet food
The FDA issued a no-objection letter for the first precision fermentation-derived animal protein intended for use in pet food.
FDA · DVM360
CDC confirms cat-to-human transmission of avian influenza
The CDC has confirmed the first known instance of cat-to-human transmission of avian influenza, as reported by the American Veterinary Medical Association.
CDC · American Veterinary Medical Association
Cat-to-human transmission of highly pathogenic avian influenza virus confirmed
DVM360 reported the confirmed cat-to-human transmission of the highly pathogenic avian influenza virus, highlighting potential zoonotic risks relevant to veterinary professionals.
DVM360
Products & Technology
Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
Orion Animal Health has received US FDA approval for Tessie (tasipimidine oral solution) to treat noise aversion and separation anxiety in dogs.
Orion Animal Health · US FDA
Orion Animal Health receives US FDA approval for Tessie®
Orion Animal Health has received US FDA approval for its Tessie product.
Orion Animal Health · FDA · GlobeNewswire
Hill's Pet Nutrition and Bond Pet Foods Receive FDA No-Objection Letter for First Animal Protein Produced via Precision Fermentation for Pet Food
Hill's Pet Nutrition and Bond Pet Foods received an FDA no-objection letter for the first animal protein produced via precision fermentation for use in pet food.
Hill's Pet Nutrition · Bond Pet Foods · FDA · PR Newswire
FDA Clears Animal Protein Ingredient Developed By Hill's Pet Nutrition
The FDA has cleared a new animal protein ingredient developed by Hill's Pet Nutrition for use in pet food products.
Hill's Pet Nutrition · FDA · ESM Magazine
Most-mentioned this week
Zoetis (1) · NVA (1)